ODOlena A. Dyndar

Olena A. Dyndar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Olena A. Dyndar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The course of delivery, the postpartum period and the condition of the newborn in women with a history of antenatal fetal death against the background of the use of a personalised complex of diagnostic and therapeutic measures

    by Nazarii Hychka, Vasyl Beniuk, Olena Dyndar, Antonina Chebotarova

    Relevance. Antenatal fetal death is one of the most severe forms of perinatal loss and accounts for 50.0% of perinatal mortality. Women with a history of antenatal fetal death belong to the group of high obstetric risk: the frequency of perinatal pathology increases threefold. Despite significant progress in perinatal medicine, there is no single effective strategy for the comprehensive management of such patients, and the morphological substrates of placental disorders remain poorly understood. Purpose. To assess the course of delivery, the postpartum period, and the condition of the newborn in women with a history of antenatal fetal death against the background of the use of a personalised complex of diagnostic and therapeutic measures. Materials and methods. A prospective study was conducted, which included 59 women with a history of antenatal fetal death who used a personalised complex (main group); comparison group – women with a history of early reproductive losses (n = 42); control group – women without reproductive losses (n = 35). The personalised complex included pre-pregnancy preparation and individualised support for pregnancy and childbirth. The timing and method of delivery, characteristics of the course of labour, the postpartum period and the condition of the newborn were assessed. Results. It was found that the frequency of premature birth in the main group was 2.3 times lower than in the comparison group, and premature rupture of amniotic fluid was 3.1 times lower (p = 0.023). Fetal distress during childbirth was recorded in 11.9% of women in the main group versus 21.4% of the comparison group (p = 0.048). The Apgar score at 1 minute in the main group significantly exceeded the indicator of the comparison group (p < 0.05). Posthypoxic encephalopathy was detected 2.8 times less often in newborns in the main group of women in labour. Morphologically, a significantly lower frequency of placental vascular fibrosis (5.1% versus 19.0%) and inflammatory infiltration of septa (5.1% versus 19.0%) was confirmed. Moderate to high levels of anxiety were detected in 8.5% of women in the main group, which is 3.4 times less common than in the comparison group (p = 0.014). Conclusions. The use of a complex of personalised diagnostic and therapeutic measures in women with a history of antenatal fetal death significantly reduced the incidence of obstetric, perinatal complications, and postpartum depressive disorders.

  • Open Access

    THE EFFECT OF PREVENTIVE THERAPY ON CEREBROVASCULAR REACTIVITY AND UTERINE ARTERY HEMODYNAMICS IN PRIMIGRAVIDAS AT HIGH RISK OF DEVELOPING PREECLAMPSIA

    by V.O. Beniuk, V.M. Komar, T.R. Nykoniuk, L.V. Manzhula, O.A. Dyndar

    Background. Despite significant progress in diagnosis and treatment, early prediction and effective prevention of preeclampsia remain pressing challenges in modern obstetric practice. Primiparous women are at increased risk of developing preeclampsia due to the specifics of uteroplacental adaptation and greater vulnerability of the endothelial system. Aim: to evaluate the impact of prophylactic therapy on cerebrovascular reactivity and uterine artery hemodynamics in primiparous women at high risk of preeclampsia and to investigate the relationship between parameters of these systems. Materials and Methods. A prospective study was conducted involving 98 primiparous women. The main group (n = 68) included patients at high risk for developing preeclampsia. Depending on the type of pharmacological prophylaxis, the main group was divided into two subgroups: Subgroup Ia (n = 36) received comprehensive preeclampsia prevention, including acetylsalicylic acid (ASA) (150 mg/day from 11–13 to 35 weeks of gestation), L-arginine (3 g/day until 35 weeks if vascular disturbances persisted), and vaginal micronized progesterone (400 mg/day until 33 weeks). Subgroup Ib (n = 32) included women who received only ASA (150 mg/day from 11–13 to 35 weeks). The control group (n = 30) consisted of low-risk pregnant women who did not receive pharmacological prophylaxis. Cerebrovascular reactivity was assessed using ophthalmic artery Doppler in the second trimester (20–22 weeks), determining the first (PSV1) and second (PSV2) peak systolic velocities, pulsatility index (PI), and the PSV2/PSV1 ratio. For comparison, uterine artery hemodynamic parameters (PI UtA) were measured in the second and third trimesters. Statistical analysis was performed using methods of variation statistics; results were considered significant at p<0.05. Results. In Ia subgroup PI UtA decreased 1.46-fold – from 1.45 ± 0.06 in the second trimester to 0.99 ± 0.09 in the third trimester – approaching the reference level of the control group, which indicates normalization of the uteroplacental blood flow under the influence of comprehensive prophylaxis. In Ib subgroup, the PI UtA decreased from 1.52 ± 0.07 to 1.04 ± 0.09; however, it remained 9.5% higher than in the control group (ANOVA p < 0.001). Doppler parameters of the ophthalmic artery in the second trimester showed that PSV1 did not differ significantly between groups (p = 0.455), indicating a baseline level of central hemodynamics. PSV2 in Ib subgroup (30.64 ± 1.24 cm/s) exceeded the values of the control group (28.42 ± 1.15 cm/s) by 7.8% and those of Ia subgroup (29.08 ± 1.36 cm/s) by 5.3% (p < 0.001). A similar trend was observed in the PSV2/PSV1 ratio: the lowest values were in the control group (0.846 ± 0.016), intermediate in Ia subgroup (0.874 ± 0.019), and the highest in Ib subgroup (0.911 ± 0.020) (p < 0.001). Conclusions. The proposed comprehensive preeclampsia prophylaxis (ASA + L-arginine + vaginal micronized progesterone) in primiparous women promotes stabilization and gradual normalization of uteroplacental blood flow throughout the second and third trimesters and maintains balanced cerebrovascular perfusion according to ophthalmic artery Doppler. Ophthalmic artery Doppler parameters (PSV2, PSV2/PSV1, PI OA) reflect cerebrovascular reactivity and correlate with high-resistance uterine artery blood flow, allowing assessment of subclinical endothelial dysfunction. The results support the use of ophthalmic artery Doppler as a tool for monitoring the effectiveness of prophylactic therapy and early prediction of preeclampsia.


  • Open Access

    ОСОБЛИВОСТІ ПЕРЕБІГУ ІІ ТРИМЕСТРУ ВАГІТНОСТІ У ЖІНОК З АНТЕНАТАЛЬНОЮ ЗАГИБЕЛЛЮ ПЛОДА В АНАМНЕЗІ НА ТЛІ ЗАПРОПОНОВАНОГО КОМПЛЕКСУ

    by В. О. Бенюк, Н. М. Гичка, І. В. Майданник, О. О. Чорна, О. А. Диндар, Т. Р. Никонюк, С. В. Бенюк

    Мета дослідження – встановити особливості перебігу ІІ триместру вагітності у жінок з антенатальною загибеллю плода (АЗП) в анамнезі на тлі комплексної індивідуалізованої терапії, спрямованої на зниження ризику ускладнень та оптимізацію акушерських наслідків. Зважаючи на поліетіологічну природу АЗП, дослідження також передбачає оцінку ефективності профілактичних заходів, диференційованих відповідно до ймовірної причини попередніх втрат. Матеріали та методи. У проспективне дослідження включено 146 жінок, які перебували під наглядом жіночої консультації у період 2021–2024 рр. Основну групу становили 84 пацієнтки з анамнезом АЗП, поділені на три клінічні підгрупи: А – з коагуляційними порушеннями, В – з інфекційним анамнезом, С – із невстановленою етіологією попередніх втрат. Контрольну групу (n=30) склали здорові жінки без ускладненого акушерського анамнезу. Усім учасницям було призначено індивідуалізований лікувально-профілактичний комплекс, що включав: гормональну підтримку прогестероном, вітамінну терапію, корекцію ендокринних та імунних показників, у підгрупі А – антикоагулянти (гепарини, ацетилсаліцилова кислота), у підгрупі В – етіотропну протимікробну терапію, у підгрупі С – фітотерапевтичні засоби. Проводили оцінку рівня статевих та плацентарних гормонів (естрiол, прогестерон, плацентарний лактоген), глюкозотолерантний тест, ультразвукова доплерометрія маткових артерій та вимірювання довжини шийки матки у ІІ триместрі. Результати дослідження та їх обговорення. Встановлено, що призначене лікування дозволяє досягти зниження частоти патологічного перебігу ІІ триместру. У жінок підгрупи А, незважаючи на наявні гемостазіологічні порушення, переважали помірні відхилення – анемія, тромбоцитопенія, порушення плацентації. Частота загрозливого невиношування у ІІ триместрі суттєво зменшилась (з 38,7 до 9,7 %, p<0,05). У підгрупі В клінічну картину переважно визначали інфекційно-запальні ускладнення (бактеріальний вагіноз, безсимптомна бактеріурія, ГРВІ), що зумовлювало зростання частоти передчасних пологів. Підгрупа С демонструвала поєднання гормональних, інфекційних та імунологічних дисфункцій. Усі підгрупи основної групи демонстрували тенденцію до підвищення прогестерону – на 39,1 % (А), 43,9 % (В) та 49,5 % (С), що підтверджує ефективність гормональної підтримки. Разом із тим рівень плацентарного лактогену та естріолу залишався достовірно нижчим, ніж у контролі. Низький естріол є прогностичним маркером ризику передчасних пологів, а плацентарний лактоген – показником функціональної повноцінності плаценти. Доплерометричні дослідження виявили підвищення систоло-діастолічного індексу (S/D) у маткових артеріях, особливо у підгрупі С. У той же час індекс резистентності залишався в межах фізіологічних коливань. Це дозволяє говорити про адаптацію судинного русла на фоні терапії. У підгрупі С виявлено достовірне скорочення довжини шийки матки ((35,4±0,7) мм), що потребувало пролонгації прогестеронової підтримки у ІІІ триместрі. Глюкозотолерантний тест виявив гестаційний діабет у 34,1 % пацієнток підгрупи С, що суттєво перевищувало показники інших груп (16,1 % у підгрупі А; 3,3 % у контролі). Це дозволяє розглядати порушення вуглеводного обміну як один із ключових факторів ризику ускладнень у жінок із АЗП невиясненої етіології....

  • Open Access

    Evaluation of the functional morphology of the myometrium in women of reproductive age with proliferative uterine disorders

    by O.A. Dyndar, I.M. Lypko, V.O. Beniuk, I.A. Usevych, T.R. Nykoniuk, L.D. Lastovetska, A.S. Chebotarova, І.м. Липко, І.а. Усевич

    The multiplicity of benign tumors and the synchrony of their occurrence are regarded as unfavorable prognostic factors indicating proliferative activity and, given the oncological alertness, determine the need for active surgical management. The high incidence of leiomyoma combined with other proliferative uterine disorders suggests it may serve as a marker of dysregulated proliferation and apoptosis in the female reproductive system.The objective: to determine the functional morphology of the myometrium in women of reproductive age with hyperplastic uterine processes.Materials and methods. The morphofunctional characteristics of intact myometrium were assessed in 60 women of reproductive age, including 30 patients with combined hyperplastic uterine processes (main group) and 30 patients with solitary uterine leiomyoma (comparison group). The study employed histological and immunohistochemical methods. The primary antibodies used were against Ki-67, p53, estrogen receptor (ER), progesterone receptor (PR), CD31, vascular endothelial growth factor (VEGF), and desmin.Results. Activation of angiogenesis in cases of combined hyperplastic uterine processes, compared with solitary leiomyomas, was indicated by a 1.3-fold increase in CD31 expression, a decrease in its optical density, a 57.0% increase in the relative expression area of VEGF, and a 56.0% increase in the optical density of VEGF expression. Hormonal sensitivity of the myometrium was characterized by a 1.5-fold higher expression of ER and a 2.3-fold reduction in PR expression.Conclusions. The morphofunctional features of the intact myometrium were characterized by a high level of ER expression (p < 0.01), a decreased level of PR expression (p < 0.05), and increased expression of VEGF (p < 0.05).

  • Open Access

    Hormonal status of reproductive age women with benign proliferative diseases of the uterus

    by O.A. Dyndar, I.M. Lypko, V.O. Beniuk, V.F. Oleshko, T.R. Nykoniuk, A.S. Chebotarova

    Proliferative diseases of the uterus are the most common gynecological pathology, and the frequency of combined development of hyperplastic processes of the endo- and myometrium is 63.0–73.0%. Uterine leiomyoma, adenomyosis and benign hyperplastic processes of the endometrium are manifestations of proliferative syndrome in the organs of the female reproductive system and indicate a number of common features of the pathogenetic mechanisms of their development.The objective: to study the hormonal status of reproductive age women with combined and solitary proliferative di-seases of the uterus.Materials and methods. 210 respondents of reproductive age (19–35 years) were examined, of which 30 women were almost health (Control Group) and 180 women had hyperplastic uterine processes, including 90 patients with combined proliferative uterine processes (Main Group) and 90 women with isolated proliferative uterine processes (Comparison Group). The hormonal status was assessed by determining the levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), estradiol, progesterone, prolactin in the blood serum, calculating the LH/FSH index and the estradiol/progesterone ratio, taking into account data of ultrasound examination of the pelvic organs. Statistical data processing was performed using the computer program Statistica 13.3.721.Results. In the case of combined uterine pathology, the hormonal homeostasis system is subjected to significantly greater stress than in the case of solitary pathology, as evidenced by a decrease in the frequency of full menstrual cycles in almost every second woman. In women with isolated hyperplastic uterine processes, anovulatory cycles and luteal phase insufficiency occur with almost the same frequency, and in combined ones, the frequency of luteal phase insufficiency exceeds the frequency of anovulatory cycles by 1.3 times. Combined forms of the benign proliferative diseases of the uterus in reproductive age women are developed in 1.6 times more because of ovarian insufficiency than the solitary ones.Conclusions. Hormonal insufficiency was found in almost every second reproductive age women with combined hyperplastic processes of the endo- and myometrium and in every third women with solitary uterine processes. Anovulation is observed in 21.1% of patients with combined and in 15.6% with isolated forms of uterine hyperplastic processes; luteal phase insufficiency – in 26.7% and 14.4% of patients, respectively (p < 0.05).

  • Open Access

    ANALYSIS OF THE FIRST TRIMESTER OF PREGNANCY COURSE IN WOMEN WITH A HISTORY OF AN ANTENATAL FETAL DEATH AGAINST THE BACKGROUND OF THE PROPOSED PREGRAVIDAL COMPLEX

    by V.O. Beniuk, N.M. Hychka, O.A. Dyndar, T.V. Kovaliuk, A.S. Chebotarova, T.K. Muliarenko, V.F. Oleshko

    Aim: to analyze the course of the first trimester of pregnancy in women with a history of antenatal fetal death against the background of the proposed preconceptional complex. Materials and methods. An analysis of 68 repeat pregnancies who were divided on the main and on the control group in the first trimester was conducted. The main group (MG) consisted of 31 pregnant women with a history of late-term pregnancy loss, in whom the main cause of previous reproductive losses was an infectious factor, and the control group (CG) included 37 pregnant women without a history of late-term reproductive losses. At the preconceptional stage, the MG group women obtained the complex which included psychological counseling in combination with immunomodulatory and antibacterial (if necessary) therapy and vaginal sanitation. In order to correct the psycho-emotional state, the vitamin-mineral complex included a drug with anxiolytic effect – temgikoluril 500 mg and a drug with an antidepressant effect on a plant basis, which included an extract of valerian roots, lemon balm leaves, and peppermint leaves. Results. Analyzing the course of the first trimester of pregnancy among the MG pregnant women, a significant majority of threatened miscarriage cases were noted – 9 (29.0%) (CG – 4 (10.8%), p0.05) detection. In the dynamics of observation, 4 (12.9%) cases of spontaneous miscarriages were found among women in the MG and 7 (18.9%) cases of spontaneous miscarriages among women in the CG, p>0.05). When evaluating the results of the systolic-diastolic ratio in MG pregnant women, an increase in the indicator by an average of 1.5 times was noted in RUA (MG – 3.2±0.37 U, CG – 2.2±0.24 U, p0.05 and β-hCG: MG – 70.4±6.9 ng/ml, CG – 79.7±7.3 ng / ml, p>0.05). During ultrasound examination in patients with a history of antenatal fetal death, an increase in the systolic-diastolic ratio in the right and left uterine arteries was noted (RUA: MG – 3.2±0.37 U, CG – 2.2±0.24 U, p<0.05 and LUA: MG – 3.4±0.47 U, CG – 2.3±0.23 U, p<0.05), which with a high degree of probability may indicate impaired trophoblast invasion into the spiral arteries with the possibility of further development of preeclampsia and fetal growth retardation.


  • Open Access

    Рerspectives on the regulation of premenstrual syndrome symptoms using phytotherapeutic approaches: results of a prospective multicenter study

    by V.O. Beniuk, V.M. Komar, O.а. Dyndar, V.M. Goncharenko, T.V. Kovaliuk, S.V. Beniuk, N.S. Oliunina

    Premenstrual syndrome (PMS) is a complex of cyclical psycho-emotional, vegetative, and metabolic disturbances that occur during the luteal phase of the menstrual cycle. In recent years, there has been an increase in the prevalence and severity of PMS manifestations, which negatively affects women’s quality of life and is considered a pressing medical and social issue.The objective: to identify the features of symptom dynamics of PMS under the influence of comprehensive phytotherapy aimed at correcting biochemical, emotional-behavioral, and reproductive indicators of the female body.Materials and methods. A prospective multicenter observational study was conducted from 2022 to 2025 at women’s outpatient clinics of communal non-commercial enterprises across all regions of Ukraine. The study included 1,413 women aged 18–40 years who had PMS symptoms. Participants received a nutraceutical with a multi-component composition containing standardized extracts of medicinal plants (Vitex agnus-castus – 150 mg, Trigonella foenum-graecum – 100 mg, Cimicifuga racemosa – 50 mg), along with vitamins and microelements with hormone-regulating, anti-inflammatory, sedative, and metabolic effects. The supplement was administered at a dose of one capsule per day for three months. Treatment effectiveness was assessed using a specially developed questionnaire that covered the main PMS symptoms – emotional-behavioral, cognitive, and somatic, as well as features of the menstrual cycle and impact on daily activity. Symptom intensity was recorded using a visual analog scale (0–3 points).Results. Analysis of PMS impact on various life domains showed significant differentiation in negative effects on general activity (76%), work (64%), education (62.5%), and interpersonal relationships (60%). Phytotherapeutic approaches led to a significant reduction in the severity of main PMS symptoms. The proportion of women with the highest levels of anger and irritability decreased from 16.1 to 0.1%, while the proportion of asymptomatic individuals increased from 28.7 to 85.5%. Similarly, there was a decreased rate of respondents with the following symptoms: feeling of helplessness, depressed mood, and self-criticism (from 10.8 to 0.1%, the rate of asymptomatic cases increased from 44.0 to 89.8%), tension and anxiety (from 13.4 to 0.2%, the asymptomatic cases – from 26.3 to 83.9%), difficulty concentrating (from 6.8 to 1.1%, the asymptomatic cases – from 49.8 to 89.9%), significant appetite changes (from 11.9 to 0.1%, the asymptomatic cases – 44.0 to 86.2%), decreased interest in daily activities (from 7.6 to 0%, asymptomatic cases – from 50.7 to 91.0%), rapid fatigue and low energy (from 11.0 to 0.1%, asymptomatic cases – to 84.4%), feelings of oppression and loss of control (from 7.4 to 0.1%, asymptomatic cases – from 55.4 to 91.7%), somatic symptoms (breast pain, bloating, weight gain, joint/muscle pain; from 22.6 to 0.1%, asymptomatic cases – from 17.5 to 78.5%), drowsiness/insomnia (from 8.6 to 0%, asymptomatic cases – from 40.4 to 88.0%), headaches (from 5.7 to 0%, asymptomatic cases – from 5.7 to 91.3%), and heartbeat (from 3.0 to 0%, asymptomatic cases – from 72.0 to 95.0%) (p < 0.05). The highest mean pre-treatment symptom scores were recorded for the somatic symptom complex (breast pain, bloating, weight gain, joint/muscle pain) – 1.43 ± 0.03 points, anger and irritability – 1.19 ± 0.03 points, feelings of depression and loss of control – 0.91 ± 0.03, and tension and anxiety – 1.19 ± 0.03. After one month of therapy, these scores decreased to 0.87 ± 0.02, 0.83 ± 0.02, 0.69 ± 0.02, and 0.92 ± 0.03 points, respectively, continuing to decline by the end of the course (3 months): to 0.26 ± 0.01, 0.16 ± 0.01, 0.21 ± 0.01, and 0.21 ± 0.01 (p < 0.05). A positive effect of the three-month therapy on menstrual function was also established: the average duration of the menstrual cycle decreased (from 32.18 ± 7.91 to 29.11 ± 4.28 days), and the average duration of menstruation decreased (from 5.91 ± 2.13 to 4.98 ± 1.12 days), with a simultaneous stabilization of both indicators within the physiological norm.Conclusions. The results of the multicenter study confirmed the clinical effectiveness of a complex product containing standardized extracts of Vitex agnus-castus (150 mg), Trigonella foenum-graecum (100 mg), Cimicifuga racemosa (50 mg), along with vitamins and microelements, in patients with PMS. The supplement reduced the severity of PMS symptoms and had a positive effect on the functional state of the reproductive system. A full three-month course of therapy contributed to a more stable therapeutic effect and the maintenance of reproductive rhythms.

  • Open Access

    Clinical and anamnestic aspects of adenomyosis

    by K.I. Susak, V.V. Kurochka, V.O. Benіuk, O.A. Dyndar, N.S. Oliunina, V.M. Komar

    The article presents the results of clinical and statistical analysis and identifies relevant aspects of adenomyosis in women of reproductive age.The objective: to study the clinical and statistical analysis of women of reproductive age with adenomyosis and its impact on the development of the disease.Materials and methods. A clinical and statistical analysis was conducted on 90 women of reproductive age with adenomyosis (main group) and 30 gynecologically healthy women of reproductive age (control group). A numerical rating scale was used to determine the intensity of pain.Results. The conducted clinical and statistical analysis of the examined groups allowed to determine possible predictors of adenomyosis in women of reproductive age. 88.9% of women have a burdened heredity. Concomitant extragenital pathology: respiratory system diseases were found in 46.7% of women, gastrointestinal tract diseases – in 42.2%. Patients of the main group had menstrual cycle disorders (100%) and decreased generative and sexual function (dyspareunia 65.5%). Burdened gynecological history included: inflammatory processes of the uterus and appendages – 52.2% of cases, pathology of the cervix – 46.7%, ovarian cysts – 15.6%; artificial abortions – 77.8%, spontaneous abortion – 20.0%, ectopic pregnancy – 8.9%. Intrauterine surgical interventions were performed: curettage of the uterine cavity – in 17.8% of women, hysteroresectoscopy – 21.1%, pathological childbirth (manual revision of the uterine walls, obstetric forceps, maternal birth trauma) – 25.6%, uterine surgery (cesarean section, suturing of the perforated hole) – 30%, appendage surgery – in 18.9%, cervical surgery – in 35.6%.Conclusions. Severe gynecological heredity, extragenital pathology, impaired immune mechanisms, hormonal imbalance, inflammatory diseases of the female genital organs, abortions, pathological childbirth, and intrauterine surgeries create a favorable background for the development and progression of adenomyosis.

  • Open Access

    PREDICTORS OF THE DEVELOPMENT OF BENIGN PROLIFERATIVE UTERINE DISEASES IN WOMEN OF REPRODUCTIVE AGE

    by O. A. Dyndar, I. M. Lypko

    Background. Among women of reproductive age, uterine leiomyoma is detected in 12-30%, endometrial hyperplastic processes in 10-18%, adenomyosis in 12-50%. The combination of uterine leiomyoma with endometrial hyperplastic processes occurs in 23-42% of cases, with internal genital endometriosis in 11-18%, in the case of genital endometriosis, pathological processes of the endometrium are diagnosed in 31.4% of patients. Aim: To determine predictors of the development of benign combined and solitary proliferative uterine diseases by examining the somatic health status and obstetric-gynecological history of women of reproductive age. Materials and methods. A questionnaire was conducted to study clinical and anamnestic indicators used to determine risk factors for the formation of combined and solitary proliferative processes of the uterus in 210 women of reproductive age, including 180 patients with proliferative diseases of the endo- and myometrium and 30 healthy women of the control group. The main group (Group I) included of 90 patients with combined proliferative processes and the comparison group (Group II) - 90 patients with isolated proliferative processes of the uterus. Results. Women with uterine leiomyoma in combination with endometrial hyperplastic processes and adenomyosis, as well as with solitary endometrial hyperplastic processes, are characterized by an older age than patients with solitary leiomyoma and adenomyosis (p<0.01). Analysis of anamnestic data of women with proliferative diseases of the uterus revealed a 1.4-fold higher frequency of childhood infectious diseases (p<0.01). In the case of combined proliferative diseases of the uterus, obesity was 1.6 times more common, diabetes mellitus and chronic pyelonephritis 1.3 times, varicose veins 2.3 times, atherosclerotic cardiosclerosis 2 times, neurocirculatory dystonia 1.8 times, irritable bowel syndrome 2.2 times, and cholelithiasis 1.6 times less common than in women with solitary proliferative diseases of the uterus (p<0.01). In women with combined and solitary proliferative diseases of the uterus, hyperpolymenorrhea occurred 6.5 and 6.2 times more often, as well as algodysmenorrhea 10 times more often (p<0.05). Women with combined and solitary proliferative diseases of the uterus gave birth 1.4 and 1.2 times less often, had a higher number of artificial abortions 3.1 and 2.6 times, spontaneous miscarriages 4.7 and 4.4 times (p<0.05), compared with healthy women. 11.1% of women with combined and 14.4% with solitary proliferative diseases of the uterus suffered from primary or secondary infertility (p<0.05). Conclusions. The conducted study shows that the premorbid background plays a significant role in the initiation and progression of proliferative processes of the endo- and myometrium, both in their solitary and combined development.


  • Preconceptional assessment of endothelial dysfunction markers in women with antenatal fetal death in anamnesis

    by N.M. Hychka, Ukraine Mnpe Maternity And Childhood Center Of The Kyiv City Clinical Hospital No. 5, V.O. Beniuk, O.A. Dyndar, A.S. Chebotarova, N.S. Nazarova, S.V. Beniuk, T.R. Nykoniuk

    Identification of endothelial dysfunction markers at stage of pregnancy planning enables risk stratification for prethrombotic conditions, optimization of preconception management strategies, and prevention of complications of pregnancy and childbirth in women with a history of antenatal fetal death (AFD). Аim - to identify markers of endothelial dysfunction and the features of polymorphism of the encoding them genes, in women with a history of AFD at the stage of preconception preparation. Materials and methods. At the stage of pregnancy planning, 38 women with a history of AFD (main group) and 35 women whose previous pregnancies resulted in live births (control group) were examined. Gene polymorphisms of coagulation factor V (FV Leiden) and 5,10-methylenetetrahydrofolate reductase (MTHFR) were determined using an allele-specific polymerase chain reaction. The presence of specific antiphospholipid antibodies and their cofactors, as well as the levels of vascular endothelial growth factor (VEGF), endothelin-1 (ET-1), and homocysteine were assessed by enzyme-linked immunosorbent assay (ELISA). Results. In women of the main group, gene polymorphisms associated with inherited thrombophilia were diagnosed 2.3 times more frequently overall. Specifically, the frequency of FV Leiden was threefold higher, MTHFR polymorphism - 3.4 times higher, prothrombin gene mutation - 5.5 times higher, and plasminogen activator inhibitor (PAI-1) polymorphism - 8.5 times higher compared to the control group. The homocysteine level in the main group exceeded that of the control group by 2.4 times. Antiphospholipid antibodies were detected three times more often in the main group and, in combination with inherited thrombophilia gene polymorphisms, were present in 21.1% of cases. A significant 3.1-fold decrease in VEGF levels and a 2.1-fold increase in ET-1 concentration were observed in women of the main group compared with the control group (6.4±0.4 pg/mL respectively 3.1±0.2 pg/mL). Conclusions. Determination of gene mutations associated with thrombophilia, antiphospholipid antibodies, and markers of endothelial dysfunction in women with a history of antenatal fetal death will enable timely adjustment of pregnancy management strategies and prevention of recurrent fetal and neonatal losses. The study was conducted in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Bioethics Committee of the Bogomolets National Medical University. Informed consent was obtained from all participants prior to their inclusion in the study. The authors declare no conflict of interest.